ANBT
NVAX icon

American National Bank & Trust’s Novavax NVAX Stock Holding History

American National Bank & Trust’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-660
Closed -$4.16K – 677
2025
Q2 		$4.16K Hold
660
– – ﹤0.01% 589
2025
Q1 		$4.23K Hold
660
– – ﹤0.01% 521
2024
Q4 		$5.31K Hold
660
– – ﹤0.01% 457
2024
Q3 		$8.34K Hold
660
– – ﹤0.01% 420
2024
Q2 		$8.36K Hold
660
– – ﹤0.01% 470
2024
Q1 		$3.15K Buy
+660
New +$3.06K ﹤0.01% 447

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American National Bank & Trust's NVAX Position: Q3 2025 in Review

American National Bank & Trust sold out of Novavax (NVAX) in Q3 2025, closing a stake of 660 shares — an estimated $4.16K sold.

American National Bank & Trust first reported a position in NVAX in Q1 2024 and held it in 6 quarters. The position peaked at $8.36K in Q2 2024. 250 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • American National Bank & Trust reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • American National Bank & Trust sold 660 Novavax shares in Q3 2025, an estimated $4.16K.
  • American National Bank & Trust first reported a position in Novavax in Q1 2024 and held it in 6 quarters.
  • American National Bank & Trust's Novavax position peaked at $8.36K in Q2 2024.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.